RxDoctor Payments DataLook up a doctor →

Jennifer Hocutt, APRN

Acute Care · Hot Springs, ARNPI 1821654880

Payments from drug & device makers

$14,877in general payments, 2019–2025

Across 670 payments — averaging $22.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • AstraZeneca$1K
  • Merck$771
  • Incyte Corporation$675
  • Pfizer$638
  • Johnson & Johnson$505
  • plus $9K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis97$1,458
AstraZeneca(2 entities)38$1,303
Merck42$771
Incyte Corporation19$675
Pfizer41$638
Johnson & Johnson(2 entities)30$505
Gilead14$458
Amgen22$419
Exelixis Inc.17$416
GSK21$408
Pharmacosmos Therapeutics Inc.12$381
Eisai Inc.13$375
Pharmacyclics LLC, An Abbvie Company15$351
Bristol Myers Squibb27$349
Lilly USA, LLC16$345
Karyopharm Therapeutics Inc.14$330
AbbVie14$321
Bayer14$302
Takeda Pharmaceuticals U.S.A., Inc.13$281
Daiichi Sankyo Inc.14$275
Astellas Pharma US Inc11$260
Sanofi11$244
Myriad Genetic Laboratories, Inc.3$225
E.r. Squibb & Sons, L.L.C.6$222
Servier Pharmaceuticals LLC3$203
Morphosys, US Inc.10$198
Epizyme, Inc.7$183
Seagen Inc.10$169
Array Biopharma Inc8$147
Rigel Pharmaceuticals, Inc.9$144
Boehringer Ingelheim6$136
Sumitomo Pharma America, Inc.5$127
Otsuka America Pharmaceutical, Inc.1$125
Travere Therapeutics, Inc.1$121
Adaptive Biotechnologies Corporation3$112
Progenics Pharmaceuticals, Inc.1$111
Dendreon Pharmaceuticals LLC1$109
Sobi, Inc6$107
Sirtex Medical Inc1$105
Grifols USA, LLC1$100
Sanofi-aventis U.S. LLC1$99
Beigene USA, Inc.5$77
Regeneron Healthcare Solutions, Inc.4$74
Pharmaessentia USA Corporation4$72
Genmab U.S., Inc.5$69
Ipsen Biopharmaceuticals, Inc4$67
Mirati Therapeutics, Inc.3$56
EMD Serono, Inc.3$56
Spectrum Pharmaceuticals Inc.3$55
Myovant Sciences Inc.3$53
Springworks Therapeutics, Inc.2$51
AVEO Pharmaceuticals, Inc.3$49
Beone Medicines USA, Inc.2$45
AMAG Pharmaceuticals, Inc.2$39
Tersera Therapeutics LLC2$38
Puma Biotechnology, Inc.2$37
Acrotech Biopharma Inc.2$33
Stemline Therapeutics Inc.2$30
Blueprint Medicines Corporation2$30
Iovance Biotherapeutics, Inc.1$29

How this compares

$14,877 in reported general payments places this provider in the 95th percentile of 321 acute care providers in Arkansas.

See all acute care providers in Arkansas →

Medicare billing

Part B allowed, 2024
$12,661
Medicare patients
38
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Hot Springs

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →